Avoid common mistakes on your manuscript.
1 Retraction to: PharmacoEconomics (2021) 39:549–561 https://doi.org/10.1007/s40273-021-01002-z
The authors have retracted this article because there is an inconsistency in the preferred model (model 4). This will lead to the worst health state (55555) receiving a higher value than 55455 and will obviously affect the values of other health states as well. All authors agree with this retraction. The authors have been invited to submit a new manuscript using a different model for peer review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Al Shabasy, S.A., Abbassi, M.M., Finch, A.P. et al. Retraction Note to: The EQ-5D-5L Valuation Study in Egypt. PharmacoEconomics 39, 971 (2021). https://doi.org/10.1007/s40273-021-01055-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40273-021-01055-0